Their study demonstrated that RAD001, an anti-tumor agent, induces an autophagy-related protein expression that increases autophagy, eventually leading to MET de-phosphorylation, and consequently enhances the chemotherapeutic response (Li N

Their study demonstrated that RAD001, an anti-tumor agent, induces an autophagy-related protein expression that increases autophagy, eventually leading to MET de-phosphorylation, and consequently enhances the chemotherapeutic response (Li N. malignancy interventions. amplification may be the cause of resistance to onartuzumab. Moreover, onartuzumab and emibetuzumab did not achieve satisfactory clinical results in Fexofenadine HCl clinical trials…